ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 44 filers reported holding ATYR PHARMA INC in Q1 2022. The put-call ratio across all filers is 3.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,885 | -83.9% | 92,332 | -78.0% | 0.00% | -100.0% |
| Q2 2023 | $908,474 | +244.4% | 420,590 | +234.8% | 0.00% | +100.0% |
| Q1 2023 | $263,794 | -25.9% | 125,616 | -22.7% | 0.00% | 0.0% |
| Q4 2022 | $355,958 | -34.1% | 162,538 | -9.7% | 0.00% | -50.0% |
| Q3 2022 | $540,000 | +6.9% | 180,014 | +0.8% | 0.00% | 0.0% |
| Q2 2022 | $505,000 | -59.9% | 178,557 | -24.1% | 0.00% | -50.0% |
| Q1 2022 | $1,259,000 | -65.4% | 235,237 | -51.7% | 0.00% | -50.0% |
| Q4 2021 | $3,638,000 | -26.0% | 486,993 | -10.1% | 0.01% | -27.3% |
| Q3 2021 | $4,919,000 | +6927.1% | 541,721 | +3650.0% | 0.01% | – |
| Q2 2021 | $70,000 | -61.5% | 14,446 | -69.1% | 0.00% | -100.0% |
| Q4 2020 | $182,000 | -63.0% | 46,826 | -69.3% | 0.00% | -50.0% |
| Q3 2020 | $492,000 | -16.2% | 152,474 | +15.4% | 0.00% | -33.3% |
| Q2 2020 | $587,000 | +226.1% | 132,123 | +105.6% | 0.00% | +200.0% |
| Q1 2020 | $180,000 | – | 64,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |